3//SEC Filing
Aisling Capital IV, LP 3
Accession 0000899243-19-001901
CIK 0001061027other
Filed
Jan 23, 7:00 PM ET
Accepted
Jan 24, 5:23 PM ET
Size
10.9 KB
Accession
0000899243-19-001901
Insider Transaction Report
Form 3
SCHIFF ANDREW N
10% Owner
Holdings
- 7,600,000(indirect: See footnote)
Common Stock
ELMS STEVE
10% Owner
Holdings
- 7,600,000(indirect: See footnote)
Common Stock
Aisling Capital IV, LP
10% Owner
Holdings
- 7,600,000(indirect: See footnote)
Common Stock
Aisling Capital Partners IV LLC
10% Owner
Holdings
- 7,600,000(indirect: See footnote)
Common Stock
Aisling Capital Partners IV, LP
10% Owner
Holdings
- 7,600,000(indirect: See footnote)
Common Stock
Footnotes (1)
- [F1]Shares held by Aisling Capital IV, LP ("Aisling"). Aisling Capital Partners IV, LP ("Aisling GP"), is the general partner of Aisling. Aisling Capital Partners IV LLC ("Aisling Partners"), is the general partner of Aisling GP. The individual managing members ("the Aisling Managers"), of Aisling Partners are Andrew Schiff, M.D. and Steve Elms. By virtue of these relationships, Aisling GP, Aisling Partners and the Aisling Managers may be deemed to have voting and investment power over the shares held by Aisling. Each of the reporting persons, other than Aisling, disclaims beneficial ownership of the shares held by Aisling, except to the extent of any pecuniary interest therein, if any.
Documents
Issuer
SUNESIS PHARMACEUTICALS INC
CIK 0001061027
Entity typeother
IncorporatedDE
Related Parties
1- filerCIK 0001652910
Filing Metadata
- Form type
- 3
- Filed
- Jan 23, 7:00 PM ET
- Accepted
- Jan 24, 5:23 PM ET
- Size
- 10.9 KB